Literature DB >> 17346608

Analysis of case-cohort data: a comparison of different methods.

N Charlotte Onland-Moret1, Daphne L van der A, Yvonne T van der Schouw, Wim Buschers, Sjoerd G Elias, Carla H van Gils, Jeroen Koerselman, Mark Roest, Diederick E Grobbee, Petra H M Peeters.   

Abstract

OBJECTIVE: The case-cohort design combines the advantages of a prospective cohort study and the efficiency of a case-control design. Usually a Cox proportional-hazards model is used for the analyses. However, adaptation of the model is necessary because of the sampling. We compared three methods that were proposed in the literature, which differ in weighting of study subjects: Prentice's, Barlow's, and Self and Prentice's method. STUDY DESIGN AND
SETTING: In a cohort of 17,357 women we studied the relationship between body mass index and cardiovascular disease (n=821) with varying subcohort sizes (sampling fraction=0.005, 0.01, 0.05, 0.10, 0.15).
RESULTS: Even with a sampling fraction of 0.01, all three methods showed identical estimates and standard errors (SE). With sampling fractions >or=0.10, results of the case-cohort analyses were similar to the full-cohort analyses. With simulations, the three methods provided different results if the full cohort is small (<1,250 subjects, subcohort=10%, 8% failures) or if the subcohort size was smaller than 15% (full cohort of 1,000 observations, 8% failures). The difference between the methods did not change with the number of failures or with different effect sizes.
CONCLUSION: In the above-mentioned situations, the effect estimates and SE of Prentice's method most resembled the estimates of the full-cohort estimates.

Entities:  

Mesh:

Year:  2007        PMID: 17346608     DOI: 10.1016/j.jclinepi.2006.06.022

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  50 in total

1.  Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease.

Authors:  Andrea Ganna; Marie Reilly; Ulf de Faire; Nancy Pedersen; Patrik Magnusson; Erik Ingelsson
Journal:  Am J Epidemiol       Date:  2012-03-06       Impact factor: 4.897

2.  Calcification of the splenic, iliac, and breast arteries and risk of all-cause and cardiovascular mortality.

Authors:  Eva J E Hendriks; Joline W J Beulens; Pim A de Jong; Yvonne T van der Schouw; Wei-Ning Sun; C Michael Wright; Michael H Criqui; Matthew A Allison; Joachim H Ix
Journal:  Atherosclerosis       Date:  2017-01-30       Impact factor: 5.162

3.  N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort.

Authors:  Mary Cushman; Suzanne E Judd; Virginia J Howard; Brett Kissela; Orlando M Gutiérrez; Nancy S Jenny; Ali Ahmed; Evan L Thacker; Neil A Zakai
Journal:  Stroke       Date:  2014-04-22       Impact factor: 7.914

4.  Fibroblast growth factor 23 and risk of incident stroke in community-living adults.

Authors:  Bhupesh Panwar; Nancy S Jenny; Virginia J Howard; Virginia G Wadley; Paul Muntner; Brett M Kissela; Suzanne E Judd; Orlando M Gutiérrez
Journal:  Stroke       Date:  2015-01-06       Impact factor: 7.914

5.  Plasma 25-Hydroxyvitamin D and the Longitudinal Risk of Sepsis in the REGARDS Cohort.

Authors:  Jordan A Kempker; Bhupesh Panwar; Suzanne E Judd; Nancy S Jenny; Henry E Wang; Orlando M Gutiérrez
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

6.  Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation.

Authors:  Rupak Shivakoti; Wei-Teng Yang; Nikhil Gupte; Sima Berendes; Alberto La Rosa; Sandra W Cardoso; Noluthando Mwelase; Cecilia Kanyama; Sandy Pillay; Wadzanai Samaneka; Cynthia Riviere; Patcharaphan Sugandhavesa; Brento Santos; Selvamuthu Poongulali; Srikanth Tripathy; Robert C Bollinger; Judith S Currier; Alice M Tang; Richard D Semba; Parul Christian; Thomas B Campbell; Amita Gupta
Journal:  Clin Infect Dis       Date:  2015-03-31       Impact factor: 9.079

7.  Vertebral fractures on routine chest computed tomography: relation with arterial calcifications and future cardiovascular events.

Authors:  Constantinus F Buckens; Pim A de Jong; Helena M Verkooijen; Harald J Verhaar; Willem P Mali; Yolanda van der Graaf
Journal:  Int J Cardiovasc Imaging       Date:  2014-12-02       Impact factor: 2.357

8.  Prediction of cardiovascular disease among hematopoietic cell transplantation survivors.

Authors:  Saro H Armenian; Dongyun Yang; Jennifer Berano Teh; Liezl C Atencio; Alicia Gonzales; F Lennie Wong; Wendy M Leisenring; Stephen J Forman; Ryotaro Nakamura; Eric J Chow
Journal:  Blood Adv       Date:  2018-07-24

9.  The PROgnostic Value of unrequested Information in Diagnostic Imaging (PROVIDI) Study: rationale and design.

Authors:  M J A Gondrie; W P Th M Mali; C F M Buckens; P C A Jacobs; D E Grobbee; Y van der Graaf
Journal:  Eur J Epidemiol       Date:  2010-10-02       Impact factor: 8.082

10.  A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Authors:  Erin E Martinez; Amy K Darke; Catherine M Tangen; Phyllis J Goodman; Jay H Fowke; Eric A Klein; Sarki A Abdulkadir
Journal:  Cancer Prev Res (Phila)       Date:  2014-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.